ADMA
ADMA BIOLOGICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$11.07
+3.65%Forward multiples
Based on analyst estimates
- P/E forward
- 13.45x
- P/E 2026E
- 13.86x
- P/E 2027E
- 11.71x
- P/E 2028E
- 9.20x
- P/S forward
- 4.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.38x
- PEG TTM
- 1.07x
- Price / book
- 6.07x
- Price / sales
- 4.84x
- Price / cash flow
- 18.14x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 4.97x
- EV / EBITDA
- 10.93x
- EV / EBIT
- 11.77x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026